Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03653897 · ClinicalTrials.gov registry record · NA
Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence
A NA study, sponsored by EtectRX.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03653897 is a NA study that has completed, run by EtectRX. The registered enrollment target is 13 participants.
The verdict
NCT03653897, a NA study, has completed, sponsored by EtectRX.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The ID-Cap System is classified as an ingestion event marker (IEM), a Class II medical device. The system is intended to record time-stamped ingestions with the ingestible sensor, ID-Tag which transmits a signal to a wearable device, the ID-Cap Reader. In this study, 12-18 subjects will ingest capsules containing ingestible sensors while wearing the Reader and being observed in a clinic setting.
Interventions
- DEVICE ID-Capsule- Active
- DEVICE Wearable Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2018-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03653897
The ClinicalTrials.gov registry entry for NCT03653897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EtectRX, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ID-Capsule- Active is the first listed.
NCT03653897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03653897 about?
NCT03653897 is a clinical study titled "Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence". The ID-Cap System is classified as an ingestion event marker (IEM), a Class II medical device. The system is intended to record time-stamped ingestions with the ingestible sensor, ID-Tag which transmits a signal to a wearable device, the ID-Cap Reader. In this study, 12-18 subjects will ingest capsu...
What is the current status of trial NCT03653897?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2018-07-31. Estimated completion is 2018-12-15.
What interventions are being tested in trial NCT03653897?
The interventions under investigation include: ID-Capsule- Active (DEVICE), Wearable Sensor (DEVICE).
Who is sponsoring clinical trial NCT03653897?
This trial is sponsored by EtectRX, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.